- Filed
- Mar 1, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Feb 29, 2024 | 1.99M sh |
| Shares Diluted restated | FY 2023 · Dec 31, 2022 | 889.54K sh |
| Capex | FY 2023 · Dec 31, 2022 | $23.18K |
| Operating Cash Flow | FY 2023 · Dec 31, 2022 | −$5.29M |
| Cash And Equivalents restated | FY 2023 · Dec 31, 2022 | $4.34M |
| Current Liabilities | FY 2023 · Dec 31, 2022 | $1.11M |
| Total Liabilities | FY 2023 · Dec 31, 2022 | $1.31M |
| Current Assets | FY 2023 · Dec 31, 2022 | $24.11M |
| Total Assets | FY 2023 · Dec 31, 2022 | $24.67M |
| Eps Diluted restated | FY 2023 · Dec 31, 2022 | −$4.97 |
| Eps Basic restated | FY 2023 · Dec 31, 2022 | −$4.97 |
| Sga Expense | FY 2023 · Dec 31, 2022 | $4.39M |
| Rd Expense | FY 2023 · Dec 31, 2022 | $3.24M |
| Net Income | FY 2023 · Dec 31, 2022 | −$4.42M |
| Operating Income | FY 2023 · Dec 31, 2022 | −$4.74M |
| Gross Profit | FY 2023 · Dec 31, 2022 | $5.75M |
| Cost Of Revenue | FY 2023 · Dec 31, 2022 | $2.51M |
| Stockholders Equity | FY 2023 · Dec 31, 2021 | $23.22M |